Comparable amounts of sex steroids are made outside the gonads in men and women: Strong lesson for hormone therapy of prostate and breast cancer

被引:86
作者
Labrie, Fernand [1 ]
Cusan, Leonello [1 ]
Gomez, Jose Luis [1 ]
Martel, Celine [1 ]
Berube, Rene [1 ]
Belanger, Patrick [1 ]
Belanger, Alain [1 ]
Vandenput, Liesbeth [2 ]
Mellstroem, Dan [2 ]
Ohlsson, Claes [2 ]
机构
[1] Laval Univ Hosp Res Ctr CRCHUL, Mol Endocrinol & Oncol Res Ctr, Quebec City, PQ G1V 4G2, Canada
[2] Gothenburg Univ, Dept Internal Med & Geriatr, Ctr Bone Res Sahlgrenska Acad CBS, Gothenburg, Sweden
关键词
Prostate cancer; Combined androgen blockade; RANDOMIZED CONTROLLED-TRIAL; MAXIMUM ANDROGEN BLOCKADE; POSTMENOPAUSAL WOMEN; REPLACEMENT THERAPY; TESTOSTERONE; DEHYDROEPIANDROSTERONE; TISSUE; CASTRATION; BIOAVAILABILITY; METABOLISM;
D O I
10.1016/j.jsbmb.2008.11.004
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The objective of this study was comparison of circulating androgens and their metabolites as well as estrogens measured for the first time by a validated mass spectrometry technology in 60-80-year-old men and women of comparable age. Castration in men (n = 34) reduces the total androgen pool by only about 60% as indicated by the decrease in the serum levels of the glucuronide metabolites of androgens compared to intact men (n = 1302). Such data are in agreement with the 50 to 75% decrease in intraprostatic dihydrotestosterone (DHT) concentration after castration. Most interestingly, the same amounts of androgens and estrogens are found in postmenopausal women (n = 369) and castrated men of comparable age. The most significant therapeutic implication of these findings is the absolute need to add a pure (nonsteroidal) antiandrogen to castration in men with prostate cancer in order to block the action of the 25 to 50% DHT left in the prostate after castration. Not adding an antiandrogen to castration in men treated for prostate cancer is equivalent to not prescribing a blocker of estrogens in women suffering from breast cancer because they are postmenopausal and have low circulating estradiol. (C) 2009 Published by Elsevier Ltd.
引用
收藏
页码:52 / 56
页数:5
相关论文
共 32 条
[1]   Trends in primary androgen depletion therapy for patients with localized and locally advanced prostate cancer: Japanese perspective [J].
Akaza, H .
CANCER SCIENCE, 2006, 97 (04) :243-247
[2]   Efficacy of primary hormone therapy for localized or locally advanced prostate cancer: results of a 10-year follow-up [J].
Akaza, Hideyuki ;
Homma, Yukio ;
Usami, Michiyuki ;
Hirao, Yoshihiko ;
Tsushima, Tomoyasu ;
Okada, Kiyoki ;
Yokoyama, Masao ;
Ohashi, Yasuo ;
Aso, Yoshio .
BJU INTERNATIONAL, 2006, 98 (03) :573-579
[3]   A randomized comparison of continuous combined transdermal delivery of estradiol-norethindrone acetate and estradiol alone for menopause [J].
Archer, DF ;
Furst, K ;
Tipping, D ;
Dain, MP ;
Vandepol, C .
OBSTETRICS AND GYNECOLOGY, 1999, 94 (04) :498-503
[4]   COMPARISON OF RESIDUAL C-19 STEROIDS IN PLASMA AND PROSTATIC TISSUE OF HUMAN, RAT AND GUINEA-PIG AFTER CASTRATION - UNIQUE IMPORTANCE OF EXTRATESTICULAR ANDROGENS IN MEN [J].
BELANGER, B ;
BELANGER, A ;
LABRIE, F ;
DUPONT, A ;
CUSAN, L ;
MONFETTE, G .
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 1989, 32 (05) :695-698
[5]   Maximum androgen blockade in advanced prostate cancer: A meta-analysis of published randomized controlled trials using nonsteroidal antiandrogens [J].
Caubet, JF ;
Tosteson, TD ;
Dong, EW ;
Naylon, EM ;
Whiting, GW ;
Ernstoff, MS ;
Ross, SD .
UROLOGY, 1997, 49 (01) :71-78
[6]  
Dalesio O, 2000, LANCET, V355, P1491
[7]   TESTOSTERONE ENHANCES ESTRADIOLS EFFECTS ON POSTMENOPAUSAL BONE-DENSITY AND SEXUALITY [J].
DAVIS, SR ;
MCCLOUD, P ;
STRAUSS, BJG ;
BURGER, H .
MATURITAS, 1995, 21 (03) :227-236
[8]   Results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) trial after completion of 5 years' adjuvant treatment for breast cancer [J].
Howell, A ;
Cuzick, J ;
Baum, M ;
Buzdar, A ;
Dowsett, M ;
Forbes, JF ;
Hoctin-Boes, G ;
Houghton, I ;
Locker, GY ;
Tobias, JS .
LANCET, 2005, 365 (9453) :60-62
[9]  
Huggins C, 1941, CANCER RES, V1, P293
[10]   ANDROGENIC ACTIVITY OF DEHYDROEPIANDROSTERONE AND ANDROSTENEDIONE IN THE RAT VENTRAL PROSTATE [J].
LABRIE, C ;
BELANGER, A ;
LABRIE, F .
ENDOCRINOLOGY, 1988, 123 (03) :1412-1417